MIRXES-B附属与印尼公司签署癌症早检合作谅解备忘录

财中社2025-08-17

8月15日，MIRXES-B（02629）发布公告，公司的间接全资附属公司MiRXES PTE.LTD.与印尼上市公司PTDIASTIKABIOTEKINDO签订了一份为期12个月的谅解备忘录，双方将就高发病率及高死亡率癌症的早期检测及诊断进行合作。主要合作活动包括在印尼销售和分销新型血源性循环microRNA及多组学癌症早期检测产品线，注册相关检测设备为医疗器械，共同开发及临床验证项目，以及提供...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2560992414?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-08-17 15:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2560992414","market":"us","top_or_hot":-1,"title":"MIRXES-B附属与印尼公司签署癌症早检合作谅解备忘录","media":"财中社","content":"<div>\n<p>8月15日，MIRXES-B（02629）发布公告，公司的间接全资附属公司MiRXES PTE.LTD.与印尼上市公司PTDIASTIKABIOTEKINDO签订了一份为期12个月的谅解备忘录，双方将就高发病率及高死亡率癌症的早期检测及诊断进行合作。主要合作活动包括在印尼销售和分销新型血源性循环microRNA及多组学癌症早期检测产品线，注册相关检测设备为医疗器械，共同开发及临床验证项目，以及提供...</p>\n\n<a href=\"http://finance.eastmoney.com/a/202508173486139020.html\">网页链接</a>\n\n</div>\n","source":"stock_eastmoney","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MIRXES-B附属与印尼公司签署癌症早检合作谅解备忘录</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMIRXES-B附属与印尼公司签署癌症早检合作谅解备忘录\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-08-17 15:24 北京时间&nbsp;&nbsp;&nbsp;<a href=http://finance.eastmoney.com/a/202508173486139020.html><strong>财中社</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>8月15日，MIRXES-B（02629）发布公告，公司的间接全资附属公司MiRXES PTE.LTD.与印尼上市公司PTDIASTIKABIOTEKINDO签订了一份为期12个月的谅解备忘录，双方将就高发病率及高死亡率癌症的早期检测及诊断进行合作。主要合作活动包括在印尼销售和分销新型血源性循环microRNA及多组学癌症早期检测产品线，注册相关检测设备为医疗器械，共同开发及临床验证项目，以及提供...</p>\n\n<a href=\"http://finance.eastmoney.com/a/202508173486139020.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02629","symbol_name":"MIRXES-B","start_time":0,"source_url":"http://finance.eastmoney.com/a/202508173486139020.html","article_id":"2560992414","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2560992414","pubTimestamp":1755415453,"columns":[],"sourceInfo":{"source_id":"stock_eastmoney","name":"东方财富"},"weMediaInfo":null,"summary":"8月15日，MIRXES-B（02629）发布公告，公司的间接全资附属公司MiRXESPTE.LTD.与印尼上市公司PTDIASTIKABIOTEKINDO签订了一份为期12个月的谅解备忘录，双方将就高发病率及高死亡率癌症的早期检测及诊断进行合作。","collect":0,"end_time":0,"defaultTopTitle":"eastmoney.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"02629":"MIRXES-B","BK1161":"生物科技"},"translate_title":"MIRXES-B affiliate signs memorandum of understanding on cooperation in early cancer detection with Indonesian company","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02629":1},"content_text":"8月15日，MIRXES-B（02629）发布公告，公司的间接全资附属公司MiRXES PTE.LTD.与印尼上市公司PTDIASTIKABIOTEKINDO签订了一份为期12个月的谅解备忘录，双方将就高发病率及高死亡率癌症的早期检测及诊断进行合作。主要合作活动包括在印尼销售和分销新型血源性循环microRNA及多组学癌症早期检测产品线，注册相关检测设备为医疗器械，共同开发及临床验证项目，以及提供开发和培训活动。　　根据世界卫生组织2022年的资料，印尼每年新增癌症病例超过350,000宗，死亡率高达70%。通过与PTDIASTIKABIOTEKINDO的合作，公司可以利用其现有渠道迅速进入印尼市场，并借助印尼的本地化政策实现业务的全球扩展。董事会相信，此次合作是公司推动全球化战略及扩展至高潜力新兴市场的重要举措。（文章来源：财中社）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2560992414","isCrawlerRequest":true}